Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Observational 5Interventional 4

Sponsor

Cancer Type

Lymphoid 21Other hematologic neoplasm 16Plasma cell 4Genitourinary 4Myeloid 3Gastrointestinal 3Thoracic 1Other solid neoplasm 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 3082Neoplasms, Plasma Cell 614Lymphoma 455Lymphoma, Non-Hodgkin 428Recurrence 371Hodgkin Disease 366Leukemia, Lymphocytic, Chronic, B-Cell 362Precursor Cell Lymphoblastic Leukemia-Lymphoma 340Leukemia, Myeloid, Acute 322Leukemia 321Myelodysplastic Syndromes 287Lymphoma, Mantle-Cell 262Lymphoma, Large B-Cell, Diffuse 259Lymphoma, Follicular 254Lymphoma, B-Cell, Marginal Zone 231Burkitt Lymphoma 227Lymphoma, Large-Cell, Immunoblastic 203Myeloproliferative Disorders 197Immunoglobulin Light-chain Amyloidosis 184Neoplasms 182Hematologic Neoplasms 169Primary Myelofibrosis 167Leukemia, Myeloid, Chronic-Phase 165Leukemia, Myeloid, Accelerated Phase 154Lymphoma, T-Cell, Cutaneous 150Waldenstrom Macroglobulinemia 145Blast Crisis 143Leukemia, Myelomonocytic, Chronic 140Mycosis Fungoides 129Sezary Syndrome 128

Interventions

ogalvibart 1crexavibart 1Therapeutics 1COVID-19 Vaccines 1COH04S1 COVID-19 vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × COVID-19 × Plasma cell × Clear all
NCT04977024 2026-02-11

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

GeoVax, Inc.

Phase 2 Active not recruiting
63 enrolled
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Multiple Myeloma

NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Scripps Translational Science Institute

Phase NA Terminated
2,117 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

NCT04805203 2023-10-19

Covimmunomm

Intergroupe Francophone du Myelome

Phase NA Terminated
139 enrolled
Plasma cell

COVID-19, Multiple Myeloma

NCT05393999 2023-04-24

SABRE

Imperial College Healthcare NHS Trust

Phase 2 Withdrawn
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡